menopausal symptoms. Any condition of the genital system affecting females, caused by pathological changes associated with the perimenopausal period, such as the permanent cessation of menstruation and infertility. Includes: Symptoms such as flushing, sleeplessness, headache,
Conditions
Interventions
Intervention 1: Intervention group: In this group, research units take a 500 mg capsule containing Rosa damascena mill hydro-alcoholic extract every 12 hours for 8 weeks. These capsules are prepared i
Sponsors
Mashhad University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
45 Years to 60 Years
Inclusion criteria
Inclusion criteria: Having a minimum education in primary school Age 45 to 65 years old Having a normal menopause (stopping menstruation for at least one year after 45 years old, without interfering with pregnancy and lactation, surgery, medication and pathology) Married and living with her husband Having sexual intercourse in the last month Obtained at least 5 score from the initial MRS Lack of known and treated medical diseases which affect the results of the study (cardiovascular, liver, kidney, chronic lung disorders, thyroid, neurology and psychiatry diseases, musculoskeletal, pelvic prolapse, urinary disorders and neurological diseases known and treated ) No history of cancer
Exclusion criteria
Exclusion criteria: Drug addiction, smoking and alcohol abuse Taken medicine that improve menopausal symptoms in the last 6 months (Such as estrogen and progesterone, GnRH agonists and antagonists, clonidine, gabapentin, serotonin and norepinephrine inhibitors, paroxetine, venlafaxine, vitamin E, methyldopa, naloxone and tibolone) Use of complementary medicine to improve menopausal symptoms (such as herbs, acupuncture and acupressure) during the last 6 months Women professional athletes or women with severe mobility limitations who are unable to do housework
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Severity of menopause symptoms. Timepoint: At the beginning of the study (before the start of the study) and at the beginning of weeks 4 and 8 after the start of the study. Method of measurement: Menopause raring scale. | — |
Secondary
| Measure | Time frame |
|---|---|
| Depression, anxiety and stress in menopausal women. Timepoint: At the beginning of the study (before the start of the study) and at the beginning of weeks 4 and 8 after the start of the study. Method of measurement: Depression, Anxiety and Stress Scale.;Quality of sleep in menopausal women. Timepoint: At the beginning of the study (before the start of the study) and at the beginning of weeks 4 and 8 after the start of the study. Method of measurement: Pittsburgh Sleep Quality Index.;Sexual function in menopausal women. Timepoint: At the beginning of the study (before the start of the study) and at the beginning of weeks 4 and 8 after the start of the study. Method of measurement: Female sexual function index. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactZohre Gholinezhad
Mashhad University of Medical Sciences
Outcome results
None listed